Affiliation:
1. Uganda National Institute of Public Health
2. Clarke International University
Abstract
Abstract
Introduction:
The presence of long-term symptoms among COVID-19 survivors is referred to as Post COVID-19 condition (PCC). In Uganda, the burden of PCC is unknown. We described the spectrum of and risk factors for PCC among persons hospitalized with COVID-19 to inform decision-making.
Methods
We conducted a retrospective cohort study among randomly-selected COVID-19 survivors hospitalized at Mulago and Entebbe Referral Hospitals during Wave 1 (October 2020-December 2020) and Wave 2 (May 2021-June 2021) of the pandemic in Uganda. A PCC case was defined as persistent, returning, or new COVID-19 symptoms occurring during the 4–12 weeks after onset for non-severe disease and during the 8–12 weeks from onset for severe disease, without an alternative diagnosis in a person with confirmed SARS-CoV-2 infection. Patients were contacted by phone, and risk factors for PCC were established using modified Poisson regression.
Findings:
Among 798 COVID-19 survivors (Wave 1: 391; Wave 2: 407), we identified 63 (16%) cases of PCC in Wave 1 and 81 (20%) in Wave 2. In Wave 1, common PCC symptoms included chest pain (14; 18%) and cough (11; 14%), while Wave 2 patients reported fatigue (16; 20%) and cough (16; 20%). Severe disease (aIRR = 2.0, 95%CI: 1.4–2.6) and any comorbidity (aIRR = 1.9, 95%CI: 1.2–2.8) during Wave 1 and any comorbidity (aIRR = 2.6, 95% CI 2.1–3.3) during Wave 2 were associated with PCC.
Interpretation:
Approximately 1 in 5 previously-hospitalized COVID-19 survivors experienced PCC during both waves, emphasizing the need for close follow-up and appropriate post-COVID-19 care.
Publisher
Research Square Platform LLC
Reference34 articles.
1. World Health Organization (WHO). WHO Director-General’s opening remarks at the media briefing on COVID-19–11 March 2020 [Internet]. [cited 2023 Sep 26]. Available from: https://www.who.int/director-general/speeches/detail/who-director-general-s-opening-remarks-at-the-media-briefing-on-covid-19---11-march-2020
2. Amin R, Sohrabi MR, Zali AR, Hannani K. Five consecutive epidemiological waves of COVID-19: a population-based cross-sectional study on characteristics, policies, and health outcome. BMC Infect Dis [Internet]. 2022 Dec 1 [cited 2023 Sep 26];22(1):1–10. Available from: https://bmcinfectdis.biomedcentral.com/articles/10.1186/s12879-022-07909-y
3. Soriano V, Ganado-Pinilla P, Sanchez-Santos M, Gómez-Gallego F, Barreiro P, de Mendoza C, Corral O. Main differences between the first and second waves of COVID-19 in Madrid, Spain. Int J Infect Dis [Internet]. 2021 Apr 1 [cited 2023 Sep 26];105:374–6. Available from: http://www.ijidonline.com/article/S1201971221002010/fulltext
4. Predicting infectious severe acute respiratory syndrome coronavirus 2 from diagnostic samples;Bullard J;Clin Infect Dis,2020
5. Features of 20 133 UK patients in hospital with covid-19 using the ISARIC WHO Clinical Characterisation Protocol: Prospective observational cohort study;Docherty AB;BMJ,2020